Paige Figi: The Cannabis Industry Is Cheering A Ban On Medicine

Much of the licensed cannabis industry is quietly counting the volume it expects to inherit from the federal hemp ban coming this November. ** Now December. What they may not realize is that the ban could eliminate the full-spectrum therapeutic hemp formulations that helped change America's view of cannabis and are used daily by an estimated 45 million Americans. The provision was written by two members of Congress, without a conference or regular order, and inserted into a massive spending bill during the longest government shutdown in American history. What should have been handled with a scalpel was done with a sledgehammer. This week we sit down with Paige Figi to discuss • Silence is a position • The scalpel Congress skipped • Oval Office, then banned Chapters 00:00 Introduction to the legislative landscape of cannabis 00:21 The impact of Charlotte's story on cannabis perception 00:48 Distinguishing hemp from marijuana in legislation 02:11 The challenges of passing therapeutic hemp laws 02:52 Congress's need for simple, effective regulation 03:48 The slow progress of therapeutic hemp legalization 04:53 The importance of clear plant distinctions 05:56 The November 12 hemp ban and its implications 07:02 The dangers of Franken hemp and synthetic cannabinoids 08:00 The public health emergency posed by recent bans 08:49 The role of science and data in regulation 10:13 The importance of industry and public unity 10:58 How regulations can support medical and adult use 12:06 The impact of federal bans on patients and consumers 13:00 The need for a balanced, science-based approach 14:00 The political landscape and legislative hurdles 14:53 The power of public advocacy and individual action 16:07 The future of cannabis regulation and industry alignment 17:06 How to effectively communicate with policymakers 18:03 The importance of clear, science-backed legislation 19:00 The role of the FDA and federal agencies 20:01 The potential for bipartisan support and progress 21:08 The significance of the November 12 deadline 22:06 The ongoing fight for access and regulation 23:04 The moral and ethical considerations in cannabis policy 23:49 How consumers can influence policy change 24:47 The importance of unity within the industry 25:46 The potential for a balanced, effective regulatory framework 27:06 The role of science and data in shaping policy 28:03 The need for responsible, clear regulations 29:02 The future outlook for therapeutic hemp and CBD 30:02 Final thoughts and call to action Guest Links https://www.coalitionforaccess.org/ https://www.instagram.com/paigefigi/ https://realmofcaring.org/about/paige-figi/ Our Links Bryan Fields on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared  global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube:  The Dime 📸 Instagram:  The Dime https://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.